NCT02720705View on ClinicalTrials.gov

Transbucal Dexmedetomidine for Prevention of Sevoflurane Emergence Agitation in Pre-school Children

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

October 31, 2018

Study Completion Date

November 30, 2018

Conditions
Agitation
Interventions
DRUG

Dexmedetomidine

oral dexmedetomidine

DRUG

saline

2ml 0.9% saline administered orally half an hour before induction of anesthesia

Trial Locations (1)

Assiut,Egypt,71571

Assiut university hospitals, Asyut

All Listed Sponsors
lead

Assiut University

OTHER

NCT02720705 - Transbucal Dexmedetomidine for Prevention of Sevoflurane Emergence Agitation in Pre-school Children | Biotech Hunter | Biotech Hunter